2 employees
Alloplex Biotherapeutics develops a cellular therapeutic platform for treating cancer.
2016
$1M
from 1 investors over 1 rounds
Alloplex Biotherapeutics, LLC raised $1M on August 19, 2021
Investors: HanAll BioPharma Co., Ltd